Full-Time
Confirmed live in the last 24 hours
Virtual care for chronic condition management
$123.2k - $161kAnnually
Mid, Senior
Remote in USA
Candidates must be based in the USA.
You match the following Omada Health's candidate preferences
Employers are more likely to interview you if you match these preferences:
Omada Health provides virtual care programs aimed at helping individuals with chronic conditions improve their health over the long term. Their approach combines clinical protocols with behavioral science to create personalized interventions for issues like diabetes prevention, weight management, hypertension, and musculoskeletal problems. These programs are evidence-based and have shown positive results in peer-reviewed studies. What sets Omada apart from competitors is their focus on creating engaging programs that encourage participants to stick with them, leading to reduced healthcare costs and improved health outcomes. The company's goal is to leverage technology and human care teams to support over half a million members across the United States, partnering with major employers and health plans to deliver effective care.
Company Size
501-1,000
Company Stage
Debt Financing
Total Funding
$436.3M
Headquarters
San Francisco, California
Founded
2011
Help us improve and share your feedback! Did you find this helpful?
Remote first - Join Omada from anywhere in the US. No matter where you’re located, we budget for travel so your team can come together.
Flexible vacation - Invest in yourself and your loved ones with flexible time away and monthly wellness days.
Parental leave - We support all new parents with competitive leave policies and flexible schedules upon return.
Omada program - Join our best-in-class program to reach your health goals, and invite a loved one to join you too.
Meeting-free days - Every Wednesday afternoon, we observe company-wide focus time with nothing on the calendar.
Resources to thrive - Invest in inclusion with resource groups, equity training, and a cross-functional team dedicated to belonging.
SAN FRANCISCO-(BUSINESS WIRE)-Omada Health, the virtual between-visit healthcare provider, is proud to announce the addition of Anne Beal, MD, MPH, to Omada's Board of Directors.
Virtual care chronic disease management vendor Omada Health files SEC paperwork for an IPO that is planned for early 2025.
Omada Health adds Sachin Jain, M.D., MBA, Julie Klapstein and Adam Stavisky to Board of Directors.
SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual-first healthcare provider, recently published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes. The study, published in The Science of Diabetes Self-Management and Care, is the latest to demonstrate the benefits of Omada’s clinically rigorous approach to behavior change. The results come on the heels of the company’s Insights Lab expansion, which established the ANSWERS initiative to focus on insights derived from combining GLP-1s with a proven behavior change approach. Omada Health offers personalized diabetes management support combining relationship-building, behavior change techniques, diabetes education, and lifestyle modification. Researchers analyzed data from more than one thousand commercially insured members with type 2 diabetes who were enrolled between January 1, 2019, and January 31, 2022, in Omada’s virtual care solution. Within this group, changes in A1C levels and weight were examined over 12 months
SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a virtual-first healthcare provider, announces its evidence-based behavior change program as one of the lifestyle support programs through EncircleRx, an Express Scripts by Evernorth solution, to help employers and health plans manage cardiodiabesity (obesity, diabetes and cardiovascular disease). The Omada program is designed to help bolster the weight loss of EncircleRx members using GLP-1 medications for weight management. With forecasted use of weight management drugs increasing to approximately nine percent of the U.S. population by 2030, Omada believes it is important to help members adopt behaviors that can improve long-term weight health before, during, and after GLP-1 use. The Omada program is designed to support members at scale in maintaining weight loss through lifestyle modifications delivered by proactive data-empowered care teams and connected devices. In the first output from the new ANSWERS Initiative, Omada partnered with Evernorth to demonstrate the real-world impact of GLP-1s alongside behavior change programs and how this collaboration can improve outcomes